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2 
Abstract 44	45	
Previous studies have shown that individuals with heroin and cocaine addiction prefer 46	
to use these drugs in distinct settings: mostly at home in the case of heroin and mostly 47	
outside the home in the case of cocaine.  Here we investigated whether the context 48	
would modulate the affective and neural responses to these drugs in a similar way. 49	
First, we used a novel emotional task to assess the affective state produced by heroin 50	
or cocaine in different settings, based on the recollections of male and female drug 51	
users.  Then we used fMRI to monitor neural activity during drug imagery (recreating 52	
the setting of drug use) in male drug users.  Consistent with our working hypothesis, 53	
the majority of participants reported a shift in the affective valence of heroin from 54	
mostly pleasant at home to mostly unpleasant outside the home (p<0.0001).  The 55	
opposite shift was observed for cocaine, that is, most participants who found cocaine 56	
pleasant outside the home found it unpleasant when taken at home (p<0.0014). 57	
Furthermore, we found a double dissociation, as a function of drug and setting 58	
imagery, in BOLD signal changes in the left prefrontal cortex and caudate, and 59	
bilaterally in the cerebellum (all p’s<0.01), suggesting that the fronto-striatal-60	
cerebellar network is implicated in the contextualization of drug-induced affect.  In 61	
summary, we report that the same setting can influence in opposite directions the 62	
affective and neural response to psychostimulants versus opiates in humans, adding to 63	
growing evidence of distinct substrates for the rewarding effects of these two drug 64	
classes. 65	66	
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Significance Statement 67	
 68	
The rewarding effects of addictive drugs are often thought to depend on shared 69	
substrates.  Yet, environmental influences can unmask striking differences between 70	
psychostimulants and opiates.  Here we used emotional tasks and fMRI to explore the 71	
influence of setting on the response to heroin versus cocaine in individuals with 72	
addiction.  Simply moving from one setting to another significantly decreased heroin 73	
pleasure but increased cocaine pleasure, and vice versa.  Similar double dissociation 74	
was observed in the activity of the fronto-striatal-cerebellar network.  These findings 75	
suggest that the effects of opiates and psychostimulants depend on dissociable 76	
psychological and neural substrates and that therapeutic approaches to addiction 77	
should take into account the peculiarities of different drug classes and the settings of 78	
drug use. 79	
  80	
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Introduction 81	
 82	
Previous studies in individuals with substance use disorder (SUD) have shown that 83	
the context in which heroin and cocaine are used can influence their reinforcing 84	
effects in a substance-specific manner.  When asked where they preferred using these 85	
drugs, they indicated distinct settings: heroin was used mostly at home whereas 86	
cocaine was used mostly outside the home, regardless of route of administration and 87	
social context (Caprioli et al., 2009; Badiani and Spagnolo, 2013).  Intravenous self-88	
administration (SA) experiments in the rat yielded similar findings.  Rats residing in 89	
the SA chambers (which is also their home environment) tend to prefer heroin to 90	
cocaine, whereas rats that do not reside in the SA chamber tend to prefer cocaine to 91	
heroin (Caprioli et al., 2009).  Many aspects of cocaine versus heroin reward appear 92	
to be modulated in opposite directions by the setting: drug intake (Caprioli et al., 93	
2007b; 2008), motivation to work for the drug (Caprioli et al., 2007b; 2008; 94	
Celentano et al., 2009), drug discrimination (Paolone et al., 2004; Caprioli et al. 95	
2007a), drug-induced ultrasonic vocalizations (Avvisati et al., 2016), and 96	
vulnerability to relapse (Montanari et al., 2015).  The findings in the rat suggest that 97	
the results obtained in humans were not the trivial consequence of a conscious 98	
decision to take a sedative drug in a place where one can relax, and an activating drug 99	
where one can move around, but reflected fundamental and substance-specific 100	
influences of setting on the response to drugs.  The question to be addressed here 101	
concerns whether such preferences may be due the fact that heroin and cocaine 102	
produce different affective states in different settings. 103	
We have proposed that the overall rewarding effects of addictive drugs are the 104	
result of a complex interaction between their central and peripheral effects and the 105	
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setting of drug use (Badiani, 2013).  Cocaine, for example, produces a state of arousal 106	
by activating noradrenergic transmission both centrally and peripherally (Billman, 107	
1995; Sofuoglu and Sewell, 2009; Maceira et al., 2014; Antoniazzi et al., 2017).  A 108	
similar state of physiological arousal usually occurs when individuals are exposed to 109	
exciting, potentially dangerous contexts.  Thus, when cocaine is taken at home, the 110	
exteroceptive information signaling a quiet environment might conflict with the 111	
interoceptive information signaling a state of arousal, resulting in a ‘mismatch’ 112	
between exteroceptive and interoceptive information.  The reverse line of reasoning 113	
applies to heroin, which depresses the central nervous system and acts in a complex 114	
manner in the periphery producing, among other effects, bradycardia (Haddad and 115	
Lasala, 1987; Thornhill et al., 1989; Nilsson et al., 2016).  Thus, when heroin is taken 116	
outside the home, there is a mismatch between exteroceptive information requiring 117	
alertness and vigilance and interoceptive information signaling reduced arousal and 118	
relaxation.  In summary, the setting of drug use provides an ‘ecological backdrop’ 119	
against which the central and peripheral effects of drugs are appraised, and when a 120	
mismatch between exteroceptive and interoceptive information is detected, the 121	
rewarding effect of the drug is thwarted. 122	
Thus, the first aim of our study was to test the hypothesis that the affective 123	
response to heroin and cocaine, as recollected by experienced drug users, would 124	
undergo opposite shifts as a function of the setting.  In particular, we hypothesized 125	
that the positive affective valence of heroin would be greater at home than outside the 126	
home, and that the opposite would occur for cocaine.   127	
Our second aim was to begin exploring the neural basis of drug-setting 128	
interactions using an emotional imagery task and functional Magnetic Resonance 129	
Imaging (fMRI).  We expected to observe changes in blood-oxygenation-level 130	
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dependent (BOLD) signal in the regions of the memory retrieval network (Bonicci et 131	
al. 2016, Kuhl and Chun 2014, Ritcher et al. 2016, Fletcher et al., 1995; Spaniol et al. 132	
2009), and a double dissociation, as a function of drug and setting, in regions 133	
implicated in drug reward processing, such as the prefrontal cortex (PFCx) and the 134	
striatum, (Volkow et al., 1999; Cox et al., 2009). 135	
 136	
Material and Methods 137	
 138	
Experiment 1 139	
 140	
Participants 141	
 142	
Prospective participants with a diagnosis of heroin or cocaine use disorder (DSM-IV 143	
or DSM-5) were recruited during their daily visit at the Substance Misuse Services of 144	
Villa Maraini (Rome, Italy) and were then screened for the following inclusion 145	
criteria: 1) age between 18 and 68 years; 2) fixed residence at the time of regular drug 146	
use; 3) good understanding of Italian or English language; 4) no psychoses, or bipolar 147	
disorders, or major depressive disorder; 5) no current alcohol dependence (as 148	
indicated by a state of inebriation at the moment of recruitment or by treatment for 149	
alcohol abuse); 6) no cognitive impairment or state of intoxication such as to preclude 150	
informed consent or valid self-report.  Before the start of the study, the participants 151	
were informed about the structure of the study and in particular that: 1) the 152	
questionnaires would focus on their current (or past) heroin and/or cocaine use; 2) the 153	
data thus collected would remain anonymous and confidential; 3) they were free to 154	
withdraw from the study at any time they wished.  After having briefed about the 155	
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study, the participants provided informed consent.  Procedures and methods were in 156	
accordance with the Declaration of Helsinki and were approved by the University of 157	
Sussex Science and Technology Cross-Schools Research Ethics Committee (C-REC).  158	
Participation in the study was voluntary, and no monetary or non-monetary incentives 159	
were offered. 160	
Fifty-three individuals (mean age=37.11, SD=10.42), who identified 161	
themselves as females (11) or males (42), participated in the experiment.  The sample 162	
included 45 heroin and cocaine users, 7 cocaine-only users, and 1 heroin-only user.  163	
All of them had a long history of heroin (15.96 years, SD=10.31) and/or cocaine 164	
(14.44 years, SD=8.51) use.  Table 1 summarizes the socio-demographic 165	
characteristics of the sample and basic information about drug use.  The majority of 166	
the participants (86.79%) had a fixed residence at the time of their enrolment in the 167	
study.  However, it is important to point out that the information concerning the 168	
setting of drug use referred to periods in which the participants had a fixed residence.   169	
 170	
Procedures 171	
 172	
The emotional state induced by the drug was assessed using a graphic approach based 173	
on the Circumplex Model of Affect (Russell, 1980), illustrated in Figure 1A, which 174	
posits that all affective states arise from the interaction of two independent 175	
neurobiological systems: arousal (along high-low energy continuum) and valence 176	
(along a pleasure-displeasure continuum).  Our aim was to develop a user-friendly, 177	
intuitive test that could be completed rapidly without relying on the cognitive 178	
processes required for the verbal description and interpretation of emotional states, 179	
which could have represented a confounding factor given the participants’ negative 180	
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feelings about their own addiction (Dearing et al., 2005; Luoma et al., 2012, 2013).  181	
Thus, we created the diagram illustrated in Figure 1B, representing a two-dimensional 182	
space of emotional state with arousal on the vertical dimension and valence on the 183	
horizontal dimension.  Emoticons and colors were added to increase the evocative 184	
power of the diagram (Nathanson et al., 2016; Kaye et al., 2017). 185	
The interview took place (during the participants’ daily visit for treatment) in a 186	
quiet medical room at the Substance Misuse Service “Villa Maraini”.  Responses 187	
were collected by the interviewer and entered into the online survey host Survey-188	
Gizmo (https://www.surveygizmo.com) using the offline mode. 189	
At the start of the interview, anonymized demographic data were collected, 190	
and the diagram (Fig. 1 B) was explained to the participants following the procedures 191	
described by Russell and Mendelsohn (1989).  The diagram was presented as a 2-D 192	
spatial map of emotional states, with the center of the circle representing a neutral 193	
state, (which is not positive or negative).  Consequently the participants could position 194	
themselves in one of the quadrants according to the following combination: i) top-195	
right yellow quadrant if the emotional state experienced was simultaneously 196	
pleasurable and arousing; ii) bottom-right green quadrant if the emotional state was 197	
simultaneously pleasurable and sedating; iii) bottom-left blue quadrant if the 198	
emotional state was simultaneously unpleasant and sedating; (iv) top-left red quadrant 199	
if the emotional state was simultaneously unpleasant and arousing.   200	
The participants were instructed to recall a typical drug experience and to rate 201	
the affective state produced by heroin versus cocaine in two settings (at home versus 202	
outside the home).  Before the interview, they were also instructed to exclude 203	
instances of combined heroin and cocaine use (‘speedball’). 204	
For each combination of drug and setting, the participants were asked to 205	
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choose the quadrant that best reflected the affective states experienced while under the 206	
influence of the drug.  Since we expected that in some case the affective state 207	
experienced while under the effect of the drug could not be reduced to a single 208	
condition, no restriction was placed on the number of affective states that the 209	
participant could report for each combination of set and setting.  In 82.7% of cases, 210	
the participants indicated a single quadrant, more rarely two quadrants (15.3%) and 211	
only in 2% of cases they selected three or four quadrants.  In 11.2% of cases, the 212	
selection of more than one quadrant resulted in a mixed valence (pleasant and 213	
unpleasant at the same time).  That is, in 88.8% of cases the valence was either 214	
entirely pleasant or entirely unpleasant. 215	
 216	
Data analysis 217	
 218	
Data were classified and analyzed in order to test two separate hypotheses.  The main 219	
working hypothesis predicted a complete or partial shift in the affective valence of 220	
heroin and cocaine as a function of setting.  Thus, the data were arranged in a 2x2 221	
contingency table, and the McNemar’s test was used to assess the difference between 222	
the two correlated proportions (McNemar, 1947).  A more rigorous reading of the 223	
working hypothesis would require limiting the analysis to the individuals who 224	
experienced heroin-induced sedation in both settings and to those who experienced 225	
cocaine-induced activation in both settings.  That is, all cases in which there was a 226	
discrepancy for the dimension ‘arousal’ were excluded from this analysis.  Also this 227	
hypothesis was tested using the McNemar’s test.  Effect size was estimated by 228	
calculating odds ratios (ODs). 229	
The second hypothesis, often surreptitiously incorporated in theoretical and 230	
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experimental frameworks, is that all drugs produce ‘pleasure’.  For each combination 231	
of drug and setting, we calculated the observed frequency of the following three 232	
categories: i) pleasant (by combining the frequency of entries for quadrants ‘pleasant-233	
arousing’ and ‘pleasant-sedating’), ii) unpleasant (by combining the frequency of 234	
entries for quadrants ‘unpleasant-arousing’ and ‘unpleasant-sedating’), and iii) mixed 235	
valence (for all the instances in which both pleasant and unpleasant quadrants were 236	
selected).  We used the one-sample Kolmogorov-Smirnov test (Massey, 1951) to 237	
assess the degree to which the observed frequencies differed from the expected 238	
frequencies based on the ‘pleasure’ hypothesis (pleasant:mixed:unpleasant = 1:0:0).  239	
We also tested a ‘weak’ version of the ‘pleasure’ hypothesis in which the categories 240	
pleasant and mixed were combined (pleasant/mixed:unpleasant = 1:0). 241	
 242	
 243	
Experiment 2 244	
 245	
Participants 246	
 247	
Prospective participants (who did no overlap with the participants in Experiments 1) 248	
with a diagnosis of heroin or cocaine dependence (DSM-IV) were recruited during 249	
their daily visit at the Substance Misuse Services of Villa Maraini and were then 250	
screened for the following inclusion criteria: 1) age between 18 and 55 years; 2) 251	
heroin and/or cocaine use at least once a week in the past 12 months; 3) fixed 252	
residence; 4) no history of neurological disorder or head trauma with loss of 253	
consciousness exceeding 30 min; 5) no other contraindication to MRI; 6) no 254	
psychoses, or bipolar disorders, or major depressive disorder; 7) no current alcohol 255	
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dependence (as indicated by a state of inebriation at the moment of recruitment or by 256	
treatment for alcohol abuse); 8) no cognitive impairment or state of intoxication such 257	
as to preclude informed consent or valid self-report.  Before the start of the study, the 258	
participants were informed about the structure of the study and in particular that: 1) 259	
they would undergo an imagery procedure during the fMRI scan; 2) the data thus 260	
collected would remain anonymous and confidential; 3) they were free to withdraw 261	
from the study at any time they wished.  After having briefed about the study, the 262	
participants provided informed consent.  Procedures and methods were in accordance 263	
with the Declaration of Helsinki and were approved by the IRCSS Santa Lucia 264	
Foundation Ethics Committee.  The participants received a flat reimbursement of 30 265	
euro for their time.  Refreshments were provided during the pre and post-scanning 266	
time. 267	
Twenty-five individuals were recruited initially.  Two individuals were 268	
excluded because of their inability to focus on imagery during training and one 269	
because of signs of distress produced by the scanner noise.  Two individuals were 270	
excluded before completing the scan because of claustrophobia.  Finally, the fMRI 271	
data from 1 participant were excluded from further analysis because of technical 272	
problems during acquisition. 273	
The sample that completed the study consisted of twenty male individuals 274	
(aged 35.35, SD=8.13) with history of both heroin (13.20±6.29 years) and cocaine 275	
(15.25±5.74 years) abuse.  Demographic information is reported in Table 2. 276	
 277	
Procedures 278	
 279	
Emotional Imagery 280	
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 281	
We adapted an emotional imagery procedure based on previous work by Lang and 282	
colleagues (Lang, 1979; Lang et al., 1980) to ask the participants to imagine taking 283	
heroin and cocaine in two different real-world settings where they had previously 284	
used these drugs. 285	
 286	
Script. The scripts for the imagery task were developed based on self-reports collected 287	
on occasion of previous studies (Caprioli et al., 2009; Badiani and Spagnolo, 2013) 288	
and of pilot interviews.  Emotional imagery procedures are capable of eliciting a 289	
mental representation that is not simply a picture scanned with the “mind’s eye” but a 290	
dynamic scenario based on real-life experience, involving high level cognitive 291	
functions such as perception, memory, emotion, and motor control (Rollins et al., 292	
1992; Kosslyn et al., 2001; Owen et al., 2006; Berger and Ehrsson, 2014).  Previous 293	
studies reported similar neural substrates for imagery and perception, demonstrating 294	
that it is possible to induce a subjective experience resembling an actual perceptual 295	
experience by using verbal instructions based on an appropriate script (Lang, 1979; 296	
Reddy et al., 2010; Cichy et al., 2012; Lee et al., 2012).  In agreement with previous 297	
studies (Lang, 1979; Lang et al., 1980; Dougherty et al., 1999; Cuthbert et al., 2003; 298	
McTeague et al., 2009; Costa et al., 2010), each script was structured to include: i) the 299	
instruction to create a mental image; ii) the description of the scenario to be imagined, 300	
that is, one of two settings: the participant’s own home (‘home’ condition) and the 301	
participant’s habitual club (‘outside-the-home’ condition); iii) the instruction to 302	
imagine oneself engaging in heroin or cocaine use (at home or outside the home) ‘as 303	
if’ it were really happening. 304	
Thus, we created two scripts for the baseline imagery task, in which 305	
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participants were asked to visualize themselves relaxing at home or in their usual 306	
club, and four scripts for the drug imagery task, one script for each combination of 307	
drug and setting: i) cocaine at home, ii) cocaine outside the home, iii) heroin at home, 308	
iv) heroin outside the home.  The scripts did not include any information specific to 309	
the individual; that is, the scripts had a standard format that was applicable to all 310	
participants (Table 3).  The scripts were then recorded and played during the imagery 311	
tasks. 312	
 313	
Training.  A week prior to the fMRI session, the participants underwent an imagery 314	
training session conducted in a quiet room at Villa Maraini.  The main aim of the 315	
session was to familiarize the participants with the imagery procedure while listening 316	
to a recording of the scanner noise through headphones and to enhance the 317	
participants’ emotional involvement during testing.  Indeed, previous studies have 318	
shown that imagery training can increase the emotional response during the imagery 319	
task (Miller et al., 1987; Sinha, 2009). 320	
The participants were asked to complete the following imagery questionnaires 321	
(adapted to Italian by Antonietti and Crespi, unpublished manuscript): 1) Vividness of 322	
Visual Imagery Questionnaire (VVIQ; Marks, 1989) in which the participants were 323	
instructed to visualize themselves in standard environmental contexts; 2) Vividness of 324	
Movements Imagery Questionnaire (VMIQ; Isaac et al., 1986) in which participants 325	
were instructed to visualize themselves while performing specific movements; 3) Test 326	
of Visual Imagery Control (TVIC; Gordon, 1949), in which the participants were 327	
instructed to operate a transformation on a mental image; 4) An adaptation of the 328	
Questionnaire on “Imagery induction of emotional state” (Wright and Mischel, 1982), 329	
in which participants were instructed to imagine situations associated with a ‘positive’ 330	
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emotional state (serene, happy, surprised and relaxed) or to a ‘negative’ emotional 331	
state (hungry, fearful, disgusted, sad).  The participants were instructed to close their 332	
eyes, to ignore as far as possible the noise of the scanner, to create a mental scenario 333	
for each condition (based on hypothetical or real events from their personal life), to 334	
imagine ‘living’ this scenario, and finally to rate the vividness of the imagery by 335	
assigning a score from 1 (not clear at all) to 5 (perfectly clear) to each item in the 336	
questionnaires.  The imagery training session lasted approximately 40 min. 337	
 338	
Emotional Imagery during the fMRI session. On the day of the fMRI scan, 339	
participants underwent a urine drug screen for amphetamine, barbiturates, 340	
benzodiazepines, cocaine, methadone, morphine/opiates, methamphetamine, and THC 341	
(Drug-Screen Multi 8TC test; nal von minden GmbH, Moers, Germany) at the 342	
Substance Misuse Service Villa Maraini (see Table 2).  They were then transferred to 343	
the Brain Imaging facility of the Santa Lucia Foundation.  Sixteen participants took 344	
their usual dose of methadone before leaving the clinic.  Smokers were allowed to 345	
smoke prior to the scan.  All the participants were blind to the content of the 346	
experimental session. 347	
Before entering the fMRI scanner, the participants received the following 348	
instructions by the experimenter: 349	
“You will be asked to imagine yourself in two different settings, specifically 350	
to be either at your own home or in your usual club. Your task will be to visualize as 351	
vividly as possible the setting in your mind and to focus intensely on this situation as 352	
if it were really happening at that moment.  You will then be asked to imagine using 353	
heroin or cocaine (but not heroin and cocaine combined, that is, no ‘speedball’) in that 354	
very same setting.  You should try to focus on the effects produced by the drug while 355	
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in that specific setting. 356	
When asked to imagine being at home it is really important that it is your own 357	
home.  You can imagine being in any part of your home (living room, bedroom, 358	
bathroom, kitchen) where you usually take or have taken the drug.  If you have never 359	
taken that drug in that setting, try to imagine how it would actually be to do so.  The 360	
imagined event should take place in the evening, at 21:00 hours. 361	
When asked to imagine being in a club, it is really important that it is, or has 362	
been, your usual club.  You can imagine being in any part of the club where you 363	
usually take or have taken the drug.  If you have never taken that drug in that setting, 364	
try to imagine how it would be to actually to do so.  The imagined event should take 365	
place in the evening, at 21:00 hours.” 366	
 367	
fMRI session 368	
 369	
The study design is outlined in Figure 2A.  During the fMRI session, each participant 370	
underwent a total of eight trials, two for each combination of drug and setting (i.e., 371	
heroin at home, cocaine at home, heroin outside, cocaine outside), in a pseudo-372	
random sequence, counterbalanced across subjects.  Subjects were equipped with 373	
headphones, and each scan was preceded by audio and video instructions guiding 374	
them through the imagery task. 375	
Each trial began with a 60-s baseline period, during which the participants 376	
were first asked to imagine relaxing either at home or outside the home.  Following 377	
this period, the participants were asked to imagine taking heroin or cocaine at home or 378	
in a club for 120 s.  This period was then followed by a 60-s rest period in which the 379	
participants were asked to stop the imagery.  Immediately after the end of each trial, 380	
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the participants rated the vividness of the imagery on using a VAS (visual analogue 381	
scale) ranging from 1 (‘not vivid at all’) to 10 (‘perfectly vivid’) displayed on a 382	
screen, using a push button controller.  The graph in Figure 2B depicts the vividness 383	
rating from each participant after the imagery period showing no significant 384	
differences between the four combinations of drug and setting. 385	
 386	
Apparatus and image acquisition 387	
 388	
Functional MRI scans sensitive to BOLD contrast were collected using a Siemens 389	
Allegra scanner (Siemens Medical Systems, Erlangen, Germany) 3.0 Tesla scanner 390	
operating at the Neuroimaging Laboratory, Foundation Santa Lucia.  Stimuli were 391	
generated by a control computer located outside the MR room, running an in-house 392	
software implemented in MatLab (Galati et al., 2008; Sulpizio et al., 2013; Boccia et 393	
al., 2015).  Instructions were presented simultaneously in audio and video modalities.  394	
An LCD video was used to project instructions to a back projector screen mounted 395	
inside the MR tube and visible through a mirror located inside the head coil.  396	
Presentation timing was synchronized by the acquisition of fMRI images.  Responses 397	
were given through push button connected to the computer by optic fibers.  Head 398	
movements were minimized by mild restraint and cushioning. 399	
Functional MRI images were acquired for the entire brain using a gradient 400	
echo planar imaging (EPI) sequence covering the whole brain (34 slices, in-plane 401	
resolution=3x3 mm, slice thickness=3 mm, inter-slice distance=1.25 mm, repetition 402	
time [TR]=2210 ms, echo time [TE]=30 ms, flip angle=70° deg). For each scan, a 403	
total of 113 fMRI volumes were acquired.  A high-resolution 3D T1-weighted MRI 404	
scan was acquired for each subject using a magnetization-prepared rapid gradient 405	
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echo sequence (Siemens MPRAGE, 176 slices, in-plane resolution= 0.5 mm, in-plane 406	
resolution=0.5x0.5 mm, slice thickness=1 mm, TR=2000 ms, TE=4.38 ms, flip 407	
angle=8° deg). 408	
 409	
Data analysis 410	
 411	
Image analyses were performed using SPM8 (Wellcome Department of Cognitive 412	
Neurology, London, UK http://www.fil.ion.ucl.ac.uk/spm) implemented in MatLab 413	
(MATLAB 2011a, The MathWorks, Inc., Natick, MA, USA).  The first four volumes 414	
of each scan were discarded to allow for T1 equilibration effects. 415	
Functional time series from each subject were temporally corrected for slice 416	
timing, using the middle volume in time as a reference, and then spatially corrected 417	
for head movement (realigned), using a least squares approach and a six-parameter 418	
rigid-body spatial transformation.  The images were then coregistered onto their T1 419	
image and spatially normalized using an automatic nonlinear stereotaxic 420	
normalization procedure (final voxel size: 3x3x3 mm) and spatially smoothed with a 421	
three dimensional Gaussian filter (6 mm full-width-half-maximum (FWHM).  The 422	
template image for spatial normalization into a standard stereotaxic space was based 423	
on Montreal Neurological Institute (MNI-152) template and conforms to a standard 424	
coordinate referencing system (Talairach and Tournoux, 1988). 425	
Images were analyzed using a standard random-effect procedure. The time 426	
series of functional MR images obtained from each participant were analyzed 427	
separately.  The effect of the experimental paradigm was estimated on a voxel by 428	
voxel basis, according to the general linear model extended to allow the analysis of 429	
fMRI data as a time series.  The model included a temporal high-pass filter to remove 430	
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low frequency confounds with a period >128 s.  Serial correlations in the fMRI time 431	
series were estimated with a restricted maximum likelihood (ReML) algorithm 432	
assuming the same correlation structure for each voxel, within each scan.  The ReML 433	
estimates were then used to whiten the data. 434	
Initially, neural activation during the imagery task was modeled as a box-car 435	
function spanning the whole duration of the imagery period and convolved with a 436	
canonical hemodynamic response function (HRF), chosen to represent the relationship 437	
between neuronal activation and blood oxygenation (Friston et al., 1998).  Images of 438	
subject-specific parameter estimates, which represented activation relative to the 439	
baseline, were calculated for each of the four drug imagery scenarios.  Inter-trial 440	
resting periods were excluded from data analysis due to the potential carryover effects 441	
of the imagery task. 442	
Using an “omnibus” F-contrast, we searched for voxels exhibiting a 443	
significant increase in BOLD signal during drug imagery (relative to baseline 444	
imagery) in any of the four imagery conditions (that is, irrespective of the specific 445	
drug-setting combination).  The resulting statistical parametric map was corrected for 446	
multiple comparisons based on family-wise error rate (FWE) and thresholded at 447	
p=0.05 corrected at voxel level (see Table 4 and Figure 4). 448	
These initial whole-brain analyses aimed at selecting a map of regions 449	
implicated in the drug imagery task.  This activation map was then used as a search 450	
mask within which to look at modulations induced by drug and setting.  We applied a 451	
deconvolution approach to the regionally averaged time courses from each region. We 452	
modeled each trial as a set of twelve finite impulse response (FIR) basis functions 453	
(Burock and Dale, 2000; Ollinger et al., 2001) spanning 10 s each, starting from the 454	
onset of the imagery task.  Such approach allows for a flexible hemodynamic 455	
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response function (HRF) modeling without any assumption on the shape of the HRF 456	
in the time period within each trial where the difference in the signal arose, although 457	
remaining in the General Linear Model (GLM) framework (Steffener et al., 2010).  To 458	
directly examine the interactions relevant to our experimental questions, the resulting 459	
regional hemodynamic responses were analyzed using a 3-way analysis of variance 460	
(ANOVA) with repeated measures on the factors drug (2 levels: heroin vs. cocaine), 461	
setting (2 levels: home vs. outside the home), and time (12 levels).  Bonferroni’s 462	
correction (p' = 1 - (1-p)1/22) was applied to the resulting p values.  Effect size was 463	
estimated by calculating partial eta squared  (ηp2) values.  464	
 465	
 466	
Results 467	
 468	
Experiment 1 469	
 470	
As illustrated in Figure 1, the affective valence of the drug experience changed as a 471	
function of both drug and setting.  When heroin was taken at home, the majority of 472	
participants reported experiencing a pleasant affective state (89.1%) or a mixed (both 473	
pleasant and unpleasant) state (4.3%), whereas only 6.5% reported an unpleasant 474	
state.  In contrast, when heroin was used outside the home, only 50% of participants 475	
reported positive (39.1%) or mixed (10.9%) affective states, whereas the other 50% 476	
reported an unpleasant experience. The opposite pattern was observed for cocaine.  477	
Cocaine at home produced a pleasurable state only in 26.9% of participants, whereas 478	
61.5% experienced an unpleasant state and 11.6% a mixed state.  In contrast, when 479	
taken outside the home cocaine produced pleasant or mixed states in the majority of 480	
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participants (50% and 17.3%, respectively) whereas 32.7% experienced an unpleasant 481	
state. 482	
Within-subject analysis of the data confirmed the main prediction of our 483	
working hypothesis.  Indeed, the valence of the affective states induced by heroin and 484	
cocaine underwent opposite shifts as a function of setting in a sizeable number of 485	
participants.  In the case of heroin, McNemar’s test indicated that the valence was 486	
more negative outside the home than at home in 26 participants, whereas the opposite 487	
shift was observed only in 1 participants (OR=26; 95%CI=3.53-191.6; p<0.0001).  In 488	
the case of cocaine, the valence was more negative at home than outside the home in 489	
24 participants, whereas the opposite shift was observed only in 6 participants (OR=4; 490	
95%CI=1.63-9.79; p=0.0014). 491	
As the working hypothesis further specified that the shift in valence was the 492	
result of a mismatch between exteroceptive and interoceptive information, the data 493	
were re-analyzed including only the cases in which there was concordance for the 494	
vertical dimension (arousal in the case of cocaine, and sedation in the case of heroin).  495	
Also this sub-set of data was consistent with the working hypothesis: the McNemar’s 496	
test indicated opposite shifts in valence, as a function of setting, for heroin (OR=6; 497	
95%CI=1.78-20.37; p<0.001) and cocaine (OR=infinity; p=0.0015). 498	
A secondary aim of the study concerned the assumption (often, albeit 499	
surreptitiously, incorporated in theoretical and experimental frameworks) that all 500	
addictive drugs produce a state of ‘pleasure’.  The Kolmogorov-Smirnov test 501	
indicated that the observed frequencies were not significantly different (p>0.2) from 502	
those expected on the basis of either the strong or the weak version of the ‘pleasure’ 503	
hypothesis (see Data Analysis in the Material and Methods section) only when heroin 504	
was used at home.  This was not the case for heroin use outside the home and for 505	
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cocaine in either setting (p<0.0001 versus either strong or weak version of the 506	
‘pleasure’ hypothesis).  In summary, only when heroin was used at home the 507	
emotional state induced by the drug was rated as being overall pleasant by the 508	
majority of participants.  This is not consistent with the idea that the primary reason 509	
for drug use is because drugs uniformly produce a pleasurable affective state. 510	
 511	
Experiment 2 512	
 513	
Overall effect of drug imagery 514	
 515	
Table 4 lists the clusters in which whole-brain analysis indicated significant changes 516	
in the BOLD signal during drug imagery relative to baseline imagery, for any of the 517	
four conditions (i.e., irrespective of drug type and setting).  Drug imagery produced 518	
significant activation in the left PFCx, (Broadman Area (BA) 6, BA 8, BA 44, BA 45, 519	
and BA 46), left supplementary motor area (BA 32), left angular gyrus, left posterior 520	
cingulum, and left precuneus.  Bilateral activation was evident in the caudate, 521	
thalamus, brain stem, inferior temporal gyrus, and cerebellum. 522	
 523	
Modulatory effect of setting on drug imagery 524	
 525	
When the data from the regions activated by drug imagery (Table 4) were again 526	
analyzed for time-dependent interaction of drug and setting in BOLD signal 527	
amplitude, we found significant drug x setting x time interaction in the middle frontal 528	
gyrus of the left PFCx (BA 44; Fig. 5, central panels), in the left caudate (Fig. 6, left 529	
panels), and bilaterally in crus I/II of the cerebellum (Fig. 6, central and right panels).  530	
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The results of the statistical analysis are detailed in Table 5.  In all these regions, the 531	
change in BOLD signal was greater when the participants were asked to imagine 532	
taking heroin outside the home and cocaine at home (the less preferred settings), 533	
compared to heroin at home and cocaine outside the home (the preferred settings).  534	
Indeed, it appears that the divergence in drug-induced BOLD signal, as a function of 535	
setting, became progressively larger during the drug imagery task (Fig. 5 and 6), 536	
probably because of a progressively greater emotional involvement of the 537	
participants.  Most important, the ηp2 values indicated a large effect size (Cohen 1988) 538	
for both drug x setting and drug x setting x time interaction in these regions.  No main 539	
effect of drug or setting was found in these regions (all Bonferroni’s corrected 540	
p’s>0.99).   541	
Drug x setting x time interaction was also found in smaller clusters in the left 542	
middle frontal gyrus (BA 8 and BA 46; Fig. 5, left and right panels), left precuneus, 543	
left temporal cortex, and right brain stem, even though it did not survive Bonferroni’s 544	
correction (all p’s≥0.3).   545	
 546	
Imagery Vividness 547	
 548	
As shown in Fig. 3B, the subjective vividness of drug imagery was virtually identical 549	
for heroin at home (8.17±0.29), heroin outside the home (7.80±0.27), cocaine at home 550	
(8.02±0.27), and cocaine outside the home (8.15±0.23), as confirmed by the 551	
Friedman’s test (χ²=3.30, p=0.3). 552	
 553	
 554	
Discussion 555	
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 556	
We report here two major findings.  First, we found that the valence of the affective 557	
state produced by heroin and cocaine in individuals with SUD shifts in opposite 558	
directions by changing the setting of drug use, heroin being experienced as more 559	
pleasant at home than outside the home, and vice versa for cocaine.  Second, when an 560	
independent sample of individuals with SUD was asked to imagine typical drug 561	
taking experiences, a double dissociation, as a function of drug and setting, in BOLD 562	
signal was observed in the dorsolateral PFCx, dorsal caudate, and cerebellum. 563	
 564	
Drug, setting, and affect 565	
 566	
On the basis of earlier findings in humans and rats (Caprioli et al. 2007a, 2007b, 567	
2008, 2009; Testa et al. 2011; De Luca and Badiani 2011; De Luca et al. 2012; 568	
Badiani and Spagnolo, 2013), it was proposed that in the presence of a mismatch 569	
between exteroceptive information (setting) and interoceptive information generated 570	
by central and peripheral drug actions, the affective valence of drug experience would 571	
be more negative than in conditions in which there was no such a mismatch (Badiani 572	
2013).  A particular instance of this theory is represented by the arousal state 573	
mismatch hypothesis.  To test this hypothesis, we identified two scenarios in which 574	
such a mismatch should occur.  In one scenario (cocaine at home), the state of arousal 575	
produced by cocaine would be at odds with a presumably quiet and safe domestic 576	
setting (but not with exciting non domestic settings).  In another scenario (heroin 577	
outside the home), the sedative effects of heroin would be at odds with exciting, 578	
potentially dangerous non-home settings (but not in a domestic setting). 579	
Consistent with the arousal state mismatch hypothesis, we found that the 580	
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affective state produced by heroin was appraised as more pleasant when the drug was 581	
used at home than when it was when used outside the home, whereas the affective 582	
state produced by cocaine was rated as more pleasant when the drug was used outside 583	
the home then when used at home.  More specifically, our data confirmed that the 584	
shift in the affective valence of heroin occurred in combination with its sedative 585	
effects, whereas the shift in the affective valence of cocaine occurred in association 586	
with its arousing effects (see Figure 3). 587	
As discussed in the Introduction, it is reasonable to assume that the 588	
sympathomimetic effects of cocaine and the parasympathomimetic-like effect of 589	
heroin contributed to generate the respective state of emotional arousal and sedation 590	
illustrated in Figure 3 (see also: Kreibig, 2010; Levenson, 2014).  Indeed, individuals 591	
with SUD report that under the influence of cocaine they experience a surge in heart 592	
rate, respiratory rate, and muscular tension, as well as a decrease in salivation, 593	
whereas when under the influence of heroin, the same individuals experience a 594	
reduction in heart rate and respiratory rate (manuscript in preparation).   595	
The finding that even prototypical addictive drugs like heroin and cocaine do 596	
not necessarily produce a pleasurable affective state in all contexts is consistent with 597	
the theory that the mechanisms underlying the motivation to use drugs are separable 598	
from those implicated in generating drug ‘pleasure’ (Robinson and Berridge, 2008; 599	
Berridge and Kringelbach, 2013).  Actually, in certain settings, almost two-thirds of 600	
experienced drug users reported that cocaine produced a mainly unpleasant affective 601	
state.  This was not entirely surprising, as it has been reported previously that cocaine 602	
induces mixed (partly aversive) motivational or affective states in both rodents (Geist 603	
& Ettenberg 1997; Ettenberg et al. 1999; Knackstedt et al. 2002) and humans 604	
(Anthony et al. 1989; Geracioti & Post 1991; Breiter et al. 1997). 605	
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 606	
Drug/setting imagery and fMRI 607	
 608	
Whole brain analysis of BOLD signal changes during drug imagery indicated 609	
activation in several brain regions, including regions that have been previously 610	
implicated in the retrieval of memories (e.g., the angular gyrus; Bonicci et al. 2016; 611	
Kuhl and Chun 2014; Ritcher et al. 2016), in mental imagery, (e.g., the precuneus; 612	
Fletcher et al., 1995; Ritcher et al. 2016), and in brain reward (e.g., the PFCx and the 613	
striatum; Goldstein and Volkow, 2002, 2011; Cox et al., 2009; Volkow et al., 2012; 614	
Leyton and Vezina, 2013). 615	
The working hypothesis predicted that the setting should alter in opposite 616	
directions the response of the PFCx and the striatum to heroin- versus cocaine-617	
imagery.  The double dissociation in BOLD signal changes in these regions confirmed 618	
our prediction.  Interestingly, the portion of the striatum involved in the interaction 619	
was the dorsal caudate and not the ventral striatum.  Previous imaging studies in drug 620	
users have reported a selective involvement of the dorsal relative to the ventral 621	
striatum (Volkow et al., 2006; Wong et al., 2006; Boileau et al., 2007; Cox et al., 622	
2017).  623	
Unexpectedly, the same pattern of dissociation seen in the PFCx and in the 624	
caudate was also found in the cerebellum – even though this should not have been 625	
entirely surprising given that the cerebellum is now thought to be implicated in drug 626	
addiction (for a review see Miquel et al., 2009; Moulton et al., 2014).  Indeed, in the 627	
past two decades, the traditional view of the cerebellum as a primarily motor structure 628	
has been amended due to increasing evidence indicating its pivotal role in the 629	
computation of cognitive and affective processes, including: i) emotional perception 630	
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and encoding; ii) evaluation of emotional contexts, bodily and facial expressions, and 631	
social interactions; iii) regulation of emotional states in relation to motor, cognitive, 632	
and context-dependent tasks (Schmahmann, 1996, 2004; Schmahmann and Sherman, 633	
1998; Scheuerecker et al., 2007; Stoodley, 2012; Buckner, 2013; Adamaszek et al., 634	
2014, 2017; Van Overwalle et al., 2015).  Cerebellar-dependent behavioral and 635	
emotional disorders have been conceptualized “as either excessive or reduced 636	
responses to the external or internal environment” (Schmahmann et al., 2007).  637	
Indeed, both positive and negative emotions are thought to be processed by cerebellar 638	
circuits (Turner et al., 2007; Baumann and Mattingley, 2012).  An rCBF PET study 639	
has shown that craving is associated to activation of the left posterior cerebellum 640	
(Kilts et al., 2001) and cerebellar activity in heroin users has been correlated with self-641	
reports of negative emotions, such as ‘feeling tense’ and ‘withdrawal symptoms’ 642	
during cue evoked craving (Sell et al., 2000).  These findings support the idea that 643	
cerebellar activation may reflect aversive processing that is not specific to drug 644	
craving.  In this respect, it is important to notice that the cerebellum is interconnected 645	
with the striatum (Hoshi et al., 2005), which is implicated in processing not only 646	
rewarding but also aversive stimuli (Ungless et al., 2004; Schultz, 2007; Leknes and 647	
Tracey, 2008), particularly the dorsal striatum (Delgado et al., 2003; Seymour et al., 648	
2007; Gorka et al., 2017).  This perspective might also help explaining why the 649	
BOLD signal in the caudate, PFCx, and cerebellum increased more when the 650	
participants imagined using heroin outside the home and cocaine at home (that is, in 651	
the presence of a mismatch) than when they imagined using heroin at home and 652	
cocaine outside the home.  Although the relationship between BOLD signal and 653	
underlying neural events is far from simple (Logothetis, 2008), it is possible that the 654	
fMRI data reflect the engagement of a fronto-striatal-cerebellar network in processing 655	
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the negative affective state produced by a mismatch between drug effects and external 656	
environment. 657	
Another interesting feature of our results is that the pattern of activation in 658	
most regions was lateralized to the left hemisphere, consistent with previous fMRI 659	
studies concerning memory retrieval (Spaniol et al., 2009). 660	
 661	
 662	
Conclusions 663	
 664	
In summary, we report here that setting of drug use exerts a substance-specific 665	
influence not only on the affective response to heroin and cocaine but also on the 666	
activity of brain regions implicated in processing drug reward and contextual 667	
information in humans, consistent with previous findings in the rat (Badiani et al., 668	
1998, 1999; Uslaner et al. 2001a, 2001b; Ferguson et al., 2004; Hope et al., 2006; 669	
Paolone et al., 2007; Celentano et al., 2009).  The within-subject design of our study 670	
makes it especially compelling because the results cannot be ascribed to individual 671	
differences drug availability, peer influence, or other socio-demographic factors. 672	
The procedures used in this study were based on retrospective reports and 673	
emotional imagery, given that it would have been next to impossible to administer 674	
alternatively heroin and cocaine to the same individual during the same fMRI 675	
procedure (and certainly not in real-world settings, which was our main focus of 676	
investigation).  In addition, because of methodological constraints, we did not 677	
measure affective or autonomic responses to drug imagery during fMRI.  To 678	
overcome these limitations, novel methodologies should be developed in order to 679	
elucidate the interoceptive and exteroceptive components of drug-setting interactions 680	
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and dissect the exact role of relevant brain networks. 681	
Finally, more research is necessary to verify whether the context can shape 682	
initial drug use and vulnerability to relapse in humans, as previously shown in rats 683	
(Caprioli et al., 2007b, 2008; Montanari et al. 2015).  Nevertheless, by emphasizing 684	
the distinctive effects of different classes of drugs and the importance of the context 685	
of drug use, our study has potential therapeutic implications, especially for the 686	
prevention of relapse in real world settings via Ecological Momentary Interventions 687	
(see Epstein et al., 2009). 688	689	
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Table 1. Socio-demographic information and diagnostic characteristics of the study 992	
sample for Experiment 1 (n=53). 993	
 994	
 Mean (SD) or % 
Drug use 
• Heroin and cocaine 
• Heroin only 
• Cocaine only 
 
84.91% 
1.89% 
13.21% 
Age (years) 37.11 (10.42) 
Sex/gender (females) 21% 
Education (years) a 11.21 (3.47) 
Ethnicity 
§ Caucasian 
§ Multiethnic 
§ Black/African 
§ Indian/Pakistani/Bangladeshi 
 
88.68% 
7.55% 
1.89% 
1.89% 
Employment status a 
§ Employed 
§ Retired/Disability 
§ Controlled environment 
§ Unemployed 
 
46.34% 
9.76% 
9.76% 
34.15% 
Fixed Residence 86.79% 
Household 
§ Family/partner 
§ Alone 
§ Flat mates 
 
82.61% 
10.87% 
6.52% 
City of residence (no. inhabitants) 
§ <100.000 
§ 10.000-100.000 
90.57% 
9.43% 
Methadone programb 
mg/day 
84.91% 
55.91 (57.24) 
Heroin 
§ Years of use 
§ Main route of administration 
• Intravenous injection 
• Inhalation (smoked) 
• Insufflation (snorted) 
n=46 
15.96 (10.31) 
 
54.35% 
23.91% 
21.74% 
Cocaine 
§ Years of use 
§ Main route of administration c 
• Intravenous injection 
• Inhalation (smoked) 
• Insufflation (snorted) 
n=52 
14.44 (8.51) 
 
26.00% 
26.00% 
48.00% 
a. 12 missing data; b. 11 missing data; c. 2 missing data. 995	
  996	
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Table 2. Socio-demographic information, diagnostic characteristics and pre-scan data 997	
for Experiment 2 (n=20). 998	
 999	
 Mean (SD) or % 
Age (years) 35.35 (8.13) 
Education (years) 13.60 (3.31) 
Employed 85% 
Handedness (left/ambidextrous/right) 5%/0%/95% 
Methadone program 
mg/day 
95% 
39.47 (30.00) 
Heroin 
§ Years of use 
§ Age of first usea 
§ Main route of administration 
• Intravenous injection 
• Inhalation (smoked) 
• Insufflation (snorted) 
 
13.20 (6.29) 
20.39 (4.30) 
 
55% 
35% 
10% 
Cocaine 
§ Years of use 
§ Age of first usea 
§ Main route of administration 
• Intravenous injection 
• Inhalation (smoked) 
• Insufflation (snorted) 
 
15.25 (5.73) 
18.83 (6.86) 
 
35% 
10% 
55% 
Pre-scan drug positiveb 
§ Methadone 
§ Morphine/opiates 
§ THC 
§ Benzodiazepines 
§ Cocaine 
§ Barbiturates 
§ Amphetamine 
§ Methamphetamine 
 
90% 
65% 
55% 
20% 
20% 
0% 
0% 
0% 
Training Imagery Questionnaires 
§ VVIQ  
§ VMIQ 
§ TVIC 
§ IIES–Positive emotional states 
§ IIES–Negative emotional states 
% participants with >50% of max. score 
90% 
90% 
95% 
90% 
90% 
VVIQ, Vividness of Visual Imagery Questionnaire; VMIQ, Vividness of Movements Imagery 
Questionnaire; TVIC, Test of Visual Imagery Control; IIES; Imagery Induction of Emotional States 
(adapted version). 
a. 2 missing data, b. 1 missing data. 	1000	
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Table 3. fMRI Imagery scripts. 1001	
 1002	
BASELINE IMAGERY 
AT HOME 
BASELINE IMAGERY 
OUTSIDE THE HOME 
1) Imagine as vividly as possible that you 
are at home. 
2) Imagine you are relaxing at home. 
1) Imagine as vividly as possible that you 
are in a club. 
2) Imagine you are relaxing in the club. 
DRUG IMAGERY 
AT HOME 
DRUG IMAGERY 
OUTSIDE THE HOME 
1) Imagine as vividly as possible that you 
are at home. 
2) Imagine using heroin at home. 
1) Imagine as vividly as possible that you 
are in a club. 
2) Imagine using heroin in the club. 
or 
1) Imagine as vividly as possible that you 
are at home. 
2) Imagine using cocaine. 
or 
1) Imagine as vividly as possible that you 
are in a club. 
2) Imagine using cocaine in the club. 
 	1003	
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Table 4. Brain Activation during drug-imagery. Whole brain analysis revealed 1004	
significant activation during drug imagery (relative to baseline imagery), for at least 1005	
one of the four drug-setting conditions, in the clusters listed below (PFWE<0.05 at the 1006	
voxel level).  Post-hoc analyses indicated significant drug x setting x time interaction 1007	
in the regions indicated in bold (see text for details).	1008	 	1009	
Cluster Anatomical region 
Extent 
(voxels) 
x y z 
Peak 
F 
Peak 
Z 
1 L. Mid. Frontal gyrus (BA8) 7 -24 17 64 13.44 5.45 
2 L. Mid. Frontal gyrus (BA46) 4 -33 56 19 11.24 4.98 
3 L. BA6, BA44, BA45 
L. Mid. Frontal gyrus (BA44) 
L. Precentral gyrus (BA6) 
L. Inf. Frontal gyrus (BA45) 
171 
69 
14 
88 
-51 
-39 
-36 
-51 
26 
11 
2 
26 
25 
34 
61 
25 
17.64 6.20 
4 L. Inf. Frontal gyrus (BA45) 17 -48 44 7 14.14 5.59 
5 L. Suppl. Motor area (BA32) 8 -6 20 46 12.07 5.16 
6 L. Post. Cingulum 24 -3 -34 31 15.01 5.75 
7 L. Inf. Parietal lobe (BA40) 170 -36 -58 40 16.60 6.30 
8 L. Angular gyrus 19 -57 -46 28 12.81 5.32 
9 L. Precuneus (BA7) 19 -9 -67 43 14.99 5.75 
10 L. Mid. Temporal gyrus (BA21) post. 28 -63 -43 -5 17.85 6.23 
11 L. Mid. Temporal gyrus (BA21) ant. 70 -60 -13 -11 14.71 5.70 
12 R. Mid. Temporal gyrus (BA21) ant. 194 51 -25 -8 26.27 7.34 
13 L./R. Caudate/Thalamus 
L. Caudate 
L. Thalamus 
R. Caudate 
R. Thalamus 
245 
62 
64 
38 
52 
0 
-18 
-3 
18 
3 
-10 
5 
-10 
5 
-7 
10 
19 
10 
16 
7 
16.51 
 
6.02 
 
14 L. Cerebellum (Crus I/II) 118 -36 -61 -32 17.85 6.23 
15 R. Cerebellum (Crus I/II) 224 15 -79 -35 20.23 6.59 
16 L. Brain stem 11 -3 -28 -14 13.77 5.52 
17 R. Brain stem 7 15 -25 -11 12.23 5.20 	 	1010	
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Table 5. Brain Activation during drug-imagery. Three-way, repeated measure, 1011	
ANOVA revealed drug x setting (F1,19) and drug x setting x time (F11,209) interactions, 1012	
and corresponding effect size (ηp2), in the brain regions listed below. 1013	 	1014	
Anatomical region Effect/Interaction F 
P 
(uncorrected) 
P 
(Bonferroni’s correction) 
ηp2 
L. BA 44 
drug x setting 
drug x setting x time 
  4.879 
10.719 
0.004 
<0.0001 
0.08 
<0.01 
0.361 
0.223 
L. Caudate 
drug x setting 
drug x setting x time 
  4.208 
  3.918 
0.054 
<0.0001 
0.70 
<0.01 
0.181 
0.171 
L. Cerebellum 
drug x setting 
drug x setting x time 
  6.452 
  3.382 
0.020 
<0.0001 
0.36 
<0.01 
0.254 
0.151 
R. Cerebellum 
drug x setting 
drug x setting x time 
  7.907 
  5.812 
0.011 
<0.0001 
0.22 
<0.01 
0.294 
0.234 	 	1015	
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Figure legends 1016	
 1017	
Figure 1. Assessment of affective states. A. Graphic representation of the 1018	
Circumplex Model of Affect (Russell 1980).  B. Bidimensional representation of 1019	
affective states used in Experiment 1.  This test was developed based on the 1020	
Circumplex Model of Affect illustrated in the left panel, by removing the labels 1021	
indicating different levels for each dimension, and by adding emoticons. 1022	
 1023	
Figure 2. Outline of the imagery task during fMRI and vividness ratings. A. 1024	
Outline of the 8 imagery trials during fMRI (2 for each combination of drug and 1025	
setting).  Each trial began with a baseline imagery period of 60 s, during which the 1026	
participant were asked to imagine relaxing either at home or outside the home.  The 1027	
participants were then asked to imagine using heroin or cocaine in the baseline setting 1028	
for 120 s (drug imagery).  This period was followed by 60 s of rest, during which the 1029	
participants were asked not to engage in imagery.  Finally, the participants were asked 1030	
to rate the vividness of the imagery on a VAS (1-10 points), by pressing a button.  1031	
Immediately after completing the VAS the next trial began. B. Vividness ratings for 1032	
individual participants. 1033	
 1034	
Figure 3.  Subjective appraisal of the emotional valence of drug experience as a 1035	
function of drug and setting.  The pie charts show the proportion of participants 1036	
reporting the affective states detailed in the legend and illustrated in Figure 6 (see text 1037	
for details) after heroin (A and B) or cocaine (C and D) use.  The McNemar’s test 1038	
indicated significant shifts in valence as a function of the setting of drug use.  Notice 1039	
that a small proportion of participants reported two affective states (hatched lines) or 1040	
more (grey). 1041	 	1042	
Figure 4. Whole brain analysis map.  The map shows regions of significant 1043	
neuronal activation during the drug imagery period, irrespective of drug and setting, 1044	
relative to the baseline imagery period.  Whole brain analysis conducted in SPM8 1045	
using an “omnibus” F contrast revealed significant changes in the regions showed 1046	
below (PFWE < 0.05 at the voxel level).  Voxels below threshold are not rendered in 1047	
color. 1048	
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 1049	 	1050	
Figure 5. BOLD signal changes in the left PFCx.  Mean (±SEM) BOLD signal 1051	
changes (A) during the drug imagery task (relative to baseline imagery) in the BA 46, 1052	
BA 44, and BA 8 obtained by averaging the values of 12 10-s bins calculated using 1053	
FIR analysis (B).  The whole brain map is the same shown in Fig. 4. 1054	
 1055	
Figure 6. BOLD signal changes in the left caudate and in the cerebellum.  Mean 1056	
(±SEM) BOLD signal changes (A) during the drug imagery task (relative to baseline 1057	
imagery) in the caudate and cerebellum obtained by averaging the values of 12 10-s 1058	
bins calculated using FIR analysis (B). 1059	
  1060	
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